Interview with Hayley Crowe, Executive VP & GM at Ecolab Global Life Sciences

Publication
Video
Conference|DCAT

Hayley Crowe, Executive VP & GM at Ecolab Global Life Sciences, talks about the company's services and how they relate to trends in bioprocessing and purification.

Current Time 0:00
Duration 4:48
Loaded: 3.42%
Stream Type LIVE
Remaining Time 4:48
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Key Learning Objectives:

    • Learn more about Ecolab’s new Life Sciences Sector and Ecolab’s investment into additional supply capacity globally.
    • Learn more about Purolite’s bioprocessing division and unique technologies.
    • Understand how Purolite is addressing key challenges and trends in bioprocessing purification.

    Recent Videos
    Training Centers and eCommerce: A Look Into Federal Equipment Company’s Pharma Innovations
    Training Centers and eCommerce: A Look Into Federal Equipment Company’s Pharma Innovations
    From Discovery to Delivery: How Piramal Pharma Limited is Strengthening its Drug Development Capabilities
    From Discovery to Delivery: How Piramal Pharma Limited is Strengthening its Drug Development Capabilities
    Inside Experic: Revolutionizing CDMO & Clinical Packaging Services
    Inside Experic: Revolutionizing CDMO & Clinical Packaging Services
    Gaylord Chemical is Now gChem
    Gaylord Chemical is Now gChem
    BioDuro is Redefining CRDMO Partnerships With End-to-End Innovation
    BioDuro is Redefining CRDMO Partnerships With End-to-End Innovation
    Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs
    Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs
    Driving Innovation in Drug Delivery: Stevanato Group’s Integrated Solutions for Evolving Patient Needs
    Driving Innovation in Drug Delivery: Stevanato Group’s Integrated Solutions for Evolving Patient Needs
    Major Growth & Investment at Pace® Life Sciences
    Major Growth & Investment at Pace® Life Sciences
    Safe, Smart, and Sustainable Packaging for the Healthcare Industry
    Safe, Smart, and Sustainable Packaging for the Healthcare Industry
    DCAT Week 2025: Industry Need for Continuous Biologics Manufacturing
    DCAT Week 2025: Industry Need for Continuous Biologics Manufacturing
    Related Content
    DCAT Week 2025: Sustainability in Medical Propellants

    DCAT Week 2025: Sustainability in Medical Propellants

    Patrick Lavery
    March 24th 2025
    Article

    PharmTech Group chatted with Markus Laubscher of Orbia during DCAT Week 2025, covering the topics of sustainability, regulatory hurdles, next-generation innovation, and the DCAT Week experience.

    TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

    SGD Pharma Details Latest Sustainability Investments at DCAT Week 2025

    Patrick Lavery
    March 19th 2025
    Article

    The company is highlighting its commitment to next-generation glass manufacturing in efforts to strengthen the pharmaceutical supply chain.

    Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

    Shilpa Biologicals and mAbTree Biologics to Collaborate on Novel Immuno-Oncology Asset

    Feliza Mirasol
    March 18th 2025
    Article

    The partnership aims to develop and commercialize a novel checkpoint inhibitor for immuno-oncology applications.

    TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

    DCAT Member Companies Present Latest News to Start DCAT Week 2025

    Patrick Lavery
    March 17th 2025
    Article

    The Member Company Announcement Forum is the kickoff event of the annual DCAT Week in New York City, which is being held from March 17–20.

    TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

    Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025

    Patrick Lavery
    March 17th 2025
    Article

    This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.

    Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

    Noramco Group Establishes Sterile Injectable Manufacturing Capabilities with $25 Million Investment

    Patrick Lavery
    March 10th 2025
    Article

    The investment is intended for the Halo Pharma facility in Whippany, NJ, and aims to help relieve capacity shortages in the injectable supply chain in the United States.